Premature ovarian insufficiency

Chairs

Riccardo Haupt, IRCCS Istituto Giannina Gaslini, Genova, Italy
W. Hamish Wallace, Royal Hospital for Sick Children, Edinburgh, United Kingdom

Coordinator

Wendy van Dorp, Erasmus Medical Center, Rotterdam, The Netherlands

Advisors

Leontien C.M. Kremer, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands and Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, the Netherlands
Melissa M. Hudson, St. Jude Children’s Research Hospital, Memphis, United States
Renée L. Mulder, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Louis S. Constine, University of Rochester Medical Center, Rochester, United States

WG leaders

Natascia Di Iorgi, Giannina Gaslini Children’s Hospital, Genova, Italy
Jennifer Levine, Weill Cornell Medicine, New York, United States
Marleen van den Berg, Emma Children’s Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, The Netherlands
Eline van Dulmen-den Broeder, Emma Children’s Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, The Netherlands

WG members

Assunta Albanese, St. George’s Hospital Medical School, London, United Kingdom
Andrea Corrias, University of Torino, Regina Margherita Children’s Hospital, Torino, Italy
Rebecca Deans, Royal Hospital for Women and University of New South Wales, Sydney, Australia
Uta Dirksen, University Children’s Hospital Muenster, Muenster, Germany
Clarisa Garcia, Hospital of the University of Pennsylvania, Philadelphia, United States
Leah Kroon, Seattle Children’s Hospital, University of Washington, Seattle, Washington, United States
Nils Lambalk, VU University Medical Center, Amsterdam, the Netherlands
Alison Leiper, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom
Lillian Meacham, Children’s Healthcare of Atlanta, Emory University, Atlanta, Georgia, United States
Alessandro Mussa, University of Torino, Regina Margherita Children’s Hospital, Torino, Italy
Sebastian Neggers, Sophia Children’s Hospital/Erasmus Medical Center, Rotterdam, the Netherlands and Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Alberto Revelli, University of Torino, S. Anna Hospital, Torino, Italy
Andy Toogood, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
Marry M. van den Heuvel-Eibrink, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands
Hanneke M. van Santen, Wilhelmina Children’s Hospital, UMC Utrecht, Utrecht, The Netherlands and Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands